Estíbaliz González de San Román Martín-rekin lankidetzan egindako argitalpenak (11)

2024

  1. Neurolipid systems: A new target for the treatment of dementia

    Basic and Clinical Pharmacology and Toxicology, Vol. 135, Núm. 3, pp. 225-236

2023

  1. Mass Spectrometry for the Advancement of Lipid Analysis in Alzheimer’s Research

    Methods in Molecular Biology (Humana Press Inc.), pp. 245-259

2021

  1. Modulation of neurolipid signaling and specific lipid species in the triple transgenic mouse model of alzheimer’s disease

    International Journal of Molecular Sciences, Vol. 22, Núm. 22

  2. Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's Disease

    ACS Chemical Neuroscience, Vol. 12, Núm. 12, pp. 2167-2181

2020

  1. Lisofosfolipidoen eta Alzheimer gaixotasunaren arteko erlazioa: etorkizuneko itu farmakologikoaren bila.

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 38, pp. 55-71

2019

  1. CB1 and LPA1 Receptors Relationship in the Mouse Central Nervous System

    Frontiers in Molecular Neuroscience, Vol. 12

2017

  1. Imaging mass spectrometry (IMS) of cortical lipids from preclinical to severe stages of Alzheimer's disease

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1859, Núm. 9, pp. 1604-1614

  2. Lipid mapping of the rat brain for models of disease

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1859, Núm. 9, pp. 1548-1557

2015

  1. Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain

    Journal of Neurochemistry, Vol. 134, Núm. 3, pp. 471-485

  2. Neurotransmitter receptor localization: From autoradiography to imaging mass spectrometry

    ACS Chemical Neuroscience, Vol. 6, Núm. 3, pp. 362-373

2014

  1. Type-1 cannabinoid receptor activity during Alzheimer's disease progression

    Journal of Alzheimer's Disease, Vol. 42, Núm. 3, pp. 761-766